Tolerability and safety of vemurafenib, cetuximab combined with camrelizumab for BRAF V600E-mutated /MSS metastatic colorectal cancer

被引：2
|
作者：
Qiu, M. [1 ]
Wei, G. [1 ]
Leng, W. [1 ]
Cao, P. [1 ]
机构：
[1] Sichuan Univ, West China Hosp, West China Sch Med, Dept Colorectal Canc Ctr, Chengdu, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.1815
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
624P
引用
收藏
页码：S446 / S446
页数：1
相关论文
共 50 条
  • [41] Safety of encorafenib, binimetinib, plus cetuximab for Japanese patients with BRAF V600E metastatic colorectal cancer
    Yamaguchi, Toshifumi
    Daisuke, Kotani
    Atsuo, Takashima
    Takeshi, Kato
    Toshiki, Masuishi
    Yoshito, Komatsu
    Manabu, Shiozawa
    Taito, Esaki
    Naoki, Izawa
    Shinji, Takeuchi
    Hideaki, Bando
    Satoru, Iwasa
    Hiroko, Hasegawa
    Taroh, Satoh
    Hiroya, Taniguchi
    Takayuki, Yoshino
    ANNALS OF ONCOLOGY, 2022, 33 : S479 - S479
  • [42] Does PD-1 blockade play a decisive role in the pathological complete remission of unresectable MSS, BRAF V600E-mutated metastatic colorectal cancer: A case report
    Tan, Li
    Li, Qing-Shu
    Peng, Dong
    Cheng, Yong
    FRONTIERS IN ONCOLOGY, 2023, 12
  • [43] BRAF V600E-mutated brain tumour in an adult patient
    Bilalovic, N.
    Hajdarpasic, E.
    Udovivic, D.
    VIRCHOWS ARCHIV, 2017, 471 : S223 - S223
  • [44] THE NATURAL HISTORY OF BRAF V600E-MUTATED GLIOBLASTOMAS IN ADULTS
    Schreck, Karisa
    Vera, Elizabeth
    Aboud, Orwa
    Acquaye, Alvina
    Boris, Lisa
    Briceno, Nicole
    Brown, Miranda
    Chung, Hye-Jung
    Crandon, Sonja
    Garren, Nancy
    Ji, Ming
    Levine, Jason
    Patel, Snehal
    Quezado, Martha
    Raffeld, Mark
    Reyes, Jennifer
    Romo, Carlos
    Siegel, Christine
    Theeler, Brett
    Xi, Liqiang
    Gilbert, Mark
    Grossman, Stuart
    Armstrong, Terri
    Wu, Jing
    NEURO-ONCOLOGY, 2018, 20 : 164 - 164
  • [45] Treatment of metastatic BRAF-V600E mutated colorectal Carcinoma
    Pamuk, Aylin
    Zander, Thomas
    Alakus, Hakan
    Bruns, Christiane
    ONKOLOGE, 2020, 26 (03): : 292 - 294
  • [46] Patient characteristics at baseline in the BERING CRC study: real-world data on BRAF V600E-mutated metastatic colorectal cancer
    Bonnin-Gruber, Y.
    Schroeder, J.
    Forstbauer, H.
    Kisro, J.
    Welslau, M.
    Mueller-Huesmann, H.
    Buerkle, D.
    Krammer-Steiner, B.
    von der Heyde, E.
    Reichenbach, F.
    Arnold, D.
    Fritsch, R.
    Gerger, A.
    Hegewisch-Becker, S.
    Vogel, A.
    Winder, T.
    Koeberle, D.
    Prager, G.
    Stintzing, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 315 - 316
  • [47] Case report: a rare case of diffusely metastatic BRAF V600E-mutated colorectal cancer with concomitant infiltration of the skin and parotid gland
    Boukouris, Aristeidis E.
    Kokkinakis, Ioannis
    Drakos, Elias
    Sfakianaki, Maria
    Tzardi, Maria
    Mavroudis, Dimitrios
    Souglakos, John
    FRONTIERS IN ONCOLOGY, 2025, 15
  • [48] Impact of BRAF/MEK inhibitor on BRAF V600E-mutated pilocytic astrocytoma
    Hamada, Ryo
    Akane, Yusuke
    Akiyama, Yukinori
    Takada, Kohichi
    Yamamoto, Masaki
    PEDIATRICS INTERNATIONAL, 2023, 65 (01)
  • [49] Conversion Surgery After Encorafenib Plus Cetuximab for Chemorefractory BRAF V600E-mutated Colorectal Cancer With Para-aortic Lymph Node Metastases
    Kawata, Ayane
    Miyamoto, Yuji
    Fukubayashi, Kotaro
    Horio, Takato
    Miyamoto, Hideaki
    Ogawa, Katsuhiro
    Ouchi, Mayuko
    Tanaka, Yasuhito
    Baba, Hideo
    IN VIVO, 2023, 37 (04): : 1797 - 1801
  • [50] BRAF V600E Inhibitor (Vemurafenib) for BRAF V600E Mutated Low Grade Gliomas
    Del Bufalo, Francesca
    Ceglie, Giulia
    Cacchione, Antonella
    Alessi, Iside
    Colafati, Giovanna Stefania
    Carai, Andrea
    Diomedi-Camassei, Francesca
    De Billy, Emmanuel
    Agolini, Emanuele
    Mastronuzzi, Angela
    Locatelli, Franco
    FRONTIERS IN ONCOLOGY, 2018, 8
12345